Trending News
Search results for: "Weight loss". 17 articles found.
The FDA authorized Eli Lilly's drug as part of a new program aimed at cutting drug approval times...
Novo and Eli Lilly are both trying to shape the narrative of their rival pills, considered to be the start of the next phase of the weight-loss drug era.
The Food and Drug Administration on Wednesday approved Eli Lilly's new GLP-1 daily pill called Foundayo. It's a new option for the millions looking to try weight loss drugs without having to use a needle and it's set to hit the market next week. It follows the approval of Novo Nordisk's Wegovy pill in December. NBC's Anne Thompson reports for TODAY.
Tech Meme - 3 hours 52 min agoErin Griffith / New York Times : How AI helped Medvi, a telehealth provider of GLP-1 weight-loss drugs with just two full-time employees, hit $401M in 2025 sales, as it tracks for $1.8B in 2026 — Matthew Gallagher took just two months, $20,000 and more than a dozen artificial intelligence tools to get his start-up off the ground.
Hello Magazine - 5 hours 3 min agoBritain's Got Talent semi-finalist Rosie O'Sullivan weighed 30 stone when she first appeared on Simon Cowell and ITV's talent contest in 2013. Since then, she has shed the weight and continues to sing...
Hello Magazine - 6 hours 58 min agoThe bestselling poet opens up about her debilitating' issues with anorexia and OCD and reveals the transformational tools that help her...
The Federal Drug Administration (FDA) has approved a new once-daily weight-loss pill from Eli Lilly, adding to the bevy of GLP-1 medications available in the consumer marketplace. The drug manufacturer announced on Tuesday that the company would begin shipping orforglipron, branded as Foundayo, as soon as Monday following approval from federal regulators. Prescribed as a...
NPR - 18 hours 50 min agoThe daily pill called Foundayo got a fast track through the Food and Drug Administration. It will compete with the pill form of Wegovy as an alternative to obesity drugs given by injection.
Called Foundayo, the tablet becomes the second one to receive FDA's green light after Novo Nordisk's Wegovy The US Food and Drug Administration (FDA) gave the green light on Wednesday to a new oral weight-loss medication developed by the Indianapolis-based pharmaceutical company Eli Lilly. Known as orforglipron or brand name Foundayo, the once-daily tablet becomes the second GLP-1 drug in pill form to hit the market in a short span of time, arriving after Novo Nordisk's Wegovy pill received...
The Food and Drug Administration on Wednesday approved Eli Lilly's pill version of a GLP-1 medication for weight loss.
Microdosing GLP-1 drugs is trending on social media and supported by some doctors, but experts warn the practice lacks a standard protocol and may undermine weight-loss results.
ABC News - 22 hours 13 min agoU.S. health officials have approved a new weight-loss pill from Eli Lilly...
Lilly says Foundayo was approved to treat obesity and can lead to long-term weight loss, alongside diet and exercise.
Hello Magazine - 22 hours 45 min agoRebel Wilson shared a realization about her 'bikini body' in a candid update about her weight loss journey after losing 80lbs...
A new daily pill, called Foundayo, is the second oral GLP-1 to reach the market in recent months, following the FDA approval of Novo Nordisk's Wegovy pill.
The FDA approval of Eli Lilly's GLP-1 pill Foundayo comes nearly three months after Novo Nordisk's oral version of Wegovy hit the market.
/https://tf-cmsv2-smithsonianmag-media.s3.amazonaws.com/filer_public/f8/f8/f8f86afc-d21d-40cc-86c9-e212d1e51222/leslie_leinwand_snake_research_0181.jpg)
Researchers discovered an appetite-suppressing molecule in python blood. If one day turned into a medication, it might lack some of the common negative side effects of GLP-1s...
GET IN TOUCH
About
Snips is the first performance-based influencer marketing platform that empowers influencers with business tools to grow their audience and monetize their social networks, while enabling brands to run performance-driven influencer programs built on true measurability & scale.